Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites. II. Female reproductive disorders.

[1]  B. Eskenazi,et al.  Prospective monitoring of early fetal loss and clinical spontaneous abortion among female semiconductor workers. , 2010, American journal of industrial medicine.

[2]  S. Swan,et al.  Bone mass and subtle abnormalities in ovulatory function in healthy women. , 1996, The Journal of clinical endocrinology and metabolism.

[3]  C. Weinberg,et al.  Timing of Sexual Intercourse in Relation to Ovulation. Effects on the Probability of Conception, Survival of the Pregnancy, and Sex of the Baby , 1995 .

[4]  B. Lasley,et al.  Methods for evaluating reproductive health of women. , 1994, Occupational medicine.

[5]  I. Cooke,et al.  The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women , 1994 .

[6]  S. Nakajima,et al.  Classification of adverse reproductive effects can be improved by measurements of multiple biomarkers for ovarian toxicity and early fetal loss. , 1993, Journal of toxicology and environmental health.

[7]  Z. Shoham,et al.  Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. , 1993, Fertility and sterility.

[8]  J. Godbold,et al.  Urinary follicle-stimulating hormone as a biological marker of ovarian toxicity. , 1993, Fertility and sterility.

[9]  N. Fournet,et al.  Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. , 1992, Fertility and sterility.

[10]  E. Krieg,et al.  Methods of monitoring menstrual function in field studies: efficacy of methods. , 1992, Reproductive toxicology.

[11]  C. Weinberg,et al.  Efficiency and Bias in Studies of Early Pregnancy Loss , 1992, Epidemiology.

[12]  S. Muasher,et al.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. , 1991, Fertility and sterility.

[13]  C. Weinberg,et al.  Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. , 1991, Statistics in medicine.

[14]  E. Kemmann,et al.  Home urinary luteinizing hormone immunoassays: clinical applications. , 1990, Fertility and sterility.

[15]  M. Wrensch,et al.  Pregnancy outcomes in women potentially exposed to solvent-contaminated drinking water in San Jose, California. , 1990, American journal of epidemiology.

[16]  S. Swan,et al.  Adverse pregnancy outcomes in relation to water contamination, Santa Clara County, California, 1980-1981. , 1989, American journal of epidemiology.

[17]  Clarice R. Weinberg,et al.  Incidence of early loss of pregnancy. , 1988, The New England journal of medicine.

[18]  M J Zinaman,et al.  The prediction of ovulation and monitoring of the fertile period , 1987, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[19]  C. Weinberg,et al.  The use of biochemical assays in epidemiologic studies of reproduction. , 1987, Environmental health perspectives.

[20]  V. Davajan,et al.  Monitoring techniques to predict and detect ovulation. , 1987, Fertility and sterility.

[21]  Campbell Kl,et al.  Methods of monitoring ovarian function and predicting ovulation: summary of a meeting. , 1985 .

[22]  K. Moghissi,et al.  Accuracy of basal body temperature for ovulation detection. , 1976, Fertility and sterility.

[23]  R. Scott,et al.  Prognostic assessment of ovarian reserve. , 1995, Fertility and sterility.

[24]  S. Swan,et al.  Exposure to organic solvents and adverse pregnancy outcome. , 1991, American journal of industrial medicine.